Sangeetha Ramanujam

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab

Alexander M. Menzies, Douglas B. Johnson, Sangeetha Ramanujam et al. · Annals of Oncology · 2016 · 823 citations · Full text

Life Sciences, Immunology, Oncology +17

Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma

Elizabeth Liniker, Alexander M. Menzies, Benjamin Y. Kong et al. · OncoImmunology · 2016 · 151 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

Samantha Bowyer, Prashanth Prithviraj, Paul Lorigan et al. · British Journal of Cancer · 2016 · 129 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Residual <scp>FDG</scp>‐<scp>PET</scp> metabolic activity in metastatic melanoma patients with prolonged response to anti‐<scp>PD</scp>‐1 therapy

Benjamin Y. Kong, Alexander M. Menzies, Catherine A.B. Saunders et al. · Pigment Cell & Melanoma Research · 2016 · 95 citations

Medicine, Nuclear Medicine, Oncology +16

Utilizing Twins Concordance Rates to Infer the Predisposition to Myasthenia Gravis

Ryan Ramanujam, Ritva Pirskanen, Sangeetha Ramanujam et al. · Twin Research and Human Genetics · 2011 · 55 citations · Full text

Life Sciences, Genetics, Immunology +17